Eagle Pharmaceuticals, Inc. Accrued Liabilities, Current
Eagle Pharmaceuticals, Inc. had Accrued Liabilities, Current of $73.20 million as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-05-09
- 2023-03-31: Accrued Liabilities, Current $73.20M.
- 2022-12-31: Accrued Liabilities, Current $85.84M.
- 2022-09-30: Accrued Liabilities, Current $73.65M.
- 2022-06-30: Accrued Liabilities, Current $67.15M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-03-31 | $73.20M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $85.84M 10-Q · filed 2023-05-09 | |
| 2022-09-30 | $73.65M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $67.15M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $63.41M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $32.34M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $27.71M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $25.53M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $21.41M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $23.82M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $24.45M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $19.78M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $20.12M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $28.36M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $27.13M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $29.45M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $22.44M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $23.52M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $22.87M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $23.22M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $13.10M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $15.39M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $20.44M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $18.68M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $15.40M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $25.24M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $21.33M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $23.34M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $19.56M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $24.41M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $14.44M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $13.54M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $15.03M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $12.16M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $9.67M 10-K · filed 2016-02-29 | |
| 2014-06-30 | $7.47M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $7.12M 10-Q · filed 2014-05-15 | |
| 2013-09-30 | $3.13M 10-K · filed 2014-12-22 | $3.13M 10-Q · filed 2014-05-15 |